# McGuff Pharmaceuticals, Inc. – FDA Inspection, Mar 31, 2017

Source: https://www.keypedia.com/records/fda_inspections/mcguff-pharmaceuticals-inc/5fff839d-7396-49b4-a06d-b1c8c086c1f0
Source feed: FDA_Inspections

> FDA inspection 1010923 of McGuff Pharmaceuticals, Inc., March 31, 2017. 15 citations under 21 CFR part 211. Form 483 issued. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010923
- Company Name: McGuff Pharmaceuticals, Inc.
- Inspection Date: 2017-03-31
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 15

## Related Documents

- [FDA Inspection 1268175 - 2025-04-28](https://www.keypedia.com/records/fda_inspections/mcguff-pharmaceuticals-inc/cb43831e-bcd5-477c-9ebc-e17f5a1a77de)
- [FDA Inspection 1229677 - 2024-08-20](https://www.keypedia.com/records/fda_inspections/mcguff-pharmaceuticals-inc/65b55a0b-b9f3-46d2-8f5d-7c4d9be18a59)
- [FDA Inspection 1228033 - 2024-01-26](https://www.keypedia.com/records/fda_inspections/mcguff-pharmaceuticals-inc/9da028b1-f0cc-456a-aa9e-f7ff6d6c6300)
- [FDA Inspection 1110847 - 2019-11-22](https://www.keypedia.com/records/fda_inspections/mcguff-pharmaceuticals-inc/a143882e-4009-464e-b098-7c78b1df6260)
- [FDA Inspection 1083919 - 2019-03-26](https://www.keypedia.com/records/fda_inspections/mcguff-pharmaceuticals-inc/05ba6d7a-07df-457c-960a-a85328df7c45)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jennifer-m-gogley/2025f306-80a6-4222-89ac-e4138028292a)
- [FDA Associated Person](https://www.keypedia.com/people/yasamin-ameri/73021772-c960-4c65-aa30-cb490866ee58)
- [Yvins Dezan](https://www.keypedia.com/people/yvins-dezan/e9fd12e6-c090-4eb6-bc78-8b80e8a90946)

Company: https://www.keypedia.com/companies/mcguff-pharmaceuticals-inc/15443041-ed2c-4d7b-8313-9c85fa0f7bc6

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b